ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Online Webinar 2019 - Live Webinar FDA's Expectations from Supplier Management for GMP: Quality Agreements and More

Date2019-11-05

Deadline2019-11-05

VenueOnine, USA - United States USA - United States

Keywords

Websitehttps://www.eventbrite.com/e/fdas-expect...5421693315

Topics/Call fo Papers

Overview
The FDA requires that manufacturers of pharmaceutical products have a documented process to assess its suppliers and contract manufacturers, that they have implemented that process, and that the process is effective. This training program will explore how having an effective supplier relationship management program will result in streamlining the supply chain, ensuring a more consistent level of quality components, materials and components, and be more cost effective to the manufacturer.
Session Highlights
Regulatory requirements for supplier qualification
Responsibilities of manufactures and suppliers
Best practices for supplier selection, qualification and management
What are the FDA’s expectations in regards to quality agreements?
What is meant by the title owner, contractor, adulterated drug, and the term manufacturing within the guidance?
Best practices for a good quality agreement
Supplier audits
Documentation requirements and audit trails
Why Should You Attend:
Failure to adequately assess and control your supplier/subcontractor pool can result in dire consequences for an organization. Assessing and approving your suppliers before placing the first order with them will eliminate many headaches for a medical device manufacturer.
Many organizations conduct supplier audits because they are required to do so by their customers or a regulatory agency. Others conduct the audits because they have been led to believe that it's a good tool for comparing various suppliers against an arbitrary list of criteria.
While all of these reasons have varying degrees of validity, none of them articulate the best reason for having a robust supplier audit program. A good supplier audit program should allow an organization to assess and periodically re-affirm the ability of key suppliers to provide conforming product consistently, reliably and on-time. It should be one of the most important initiatives toward fulfilling the goal of having a sustainable supply chain.
This webinar will provide attendees with the information and tools necessary to develop, implement, and effectively utilize and maintain a program for supplier quality management that will satisfy the FDA’s requirements without creating undue burdens for the organization.
Learning Objectives:
Understanding the FDA’s requirements for medical device supplier assessment and approvals
Learning “who” are considered to be suppliers
Knowing how to structure a supplier quality agreement
Selecting the potential methods for evaluating and assessing suppliers
Who Will Benefit:
Quality Assurance/Quality Control Directors, Managers, and Specialists
Regulatory Affairs/Regulatory Compliance Directors, Managers, and Specialists
Purchasing/Materials Management Directors, Managers, and Specialists
Engineering/Development Directors, Managers, and Specialists
Document Control Managers and Specialists
Speaker Profile
Danielle DeLucy, MS, is currently an independent consultant to the biologics and pharmaceutical industries specializing in the areas of quality assurance and quality systems. Prior to this role, Ms. DeLucy has been in the industry for 15 years serving in numerous quality management roles, such as the director of product quality, the oversight of sterility assurance practices and provided QA oversight of numerous filling and packaging operations.
Ms. DeLucy began her QA career as a quality control pharmaceutical microbiologist at Lancaster Laboratories, a contract laboratory where she performed various tests for their clients. In the years after, she has held positions in the quality management arena while increasing her responsibility. She has helped lead many regulatory health inspections and was instrumental in the coaching process of her peers prior to any inspection. Currently, she assists companies who are faced with warning letters and consent decrees establish more robust quality systems so that the company can succeed.

Last modified: 2019-10-10 19:52:17